Clinical Trial Detail

NCT ID NCT01999738
Title Folic Acid-Tubulysin Conjugate EC1456 In Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Endocyte
Indications

hepatocellular carcinoma

ovarian cancer

Advanced Solid Tumor

lung non-small cell carcinoma

triple-receptor negative breast cancer

Therapies

EC1456

Age Groups: adult

No variant requirements are available.